Initial data about an experimental drug called remdesivir has been touted as showing promise for a potential treatment for COVID-19, the disease caused by the novel coronavirus.
Dr. Anthony Fauci, the top infectious diseases expert in the United States, has said he expects the Food and Drug Administration to fast-track approval of the drug, which was shown in a study to shorten recovery time of hospitalized patients.
Global News spoke with two Canadian scientists about their thoughts on the early findings on remdesivir, how the drug works and what the next steps are.
Dr. Rob Fowler from Toronto’s Sunnybrook Hospital said it’s too early to read into the results of the preliminary data out of the U.S.